Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders
Organophosphate compounds (OPs) interfere with neurodevelopment and are neurotoxic for humans and animals. They are first biotransformed to the more toxic oxon form, and then hydrolyzed to specific metabolites by the enzyme paraoxonase/arylesterase, encoded by the gene <i>PON1</i> locate...
Main Authors: | Ignazio Stefano Piras, Stefano Gabriele, Laura Altieri, Federica Lombardi, Roberto Sacco, Carla Lintas, Barbara Manzi, Paolo Curatolo, Maria Nobile, Catia Rigoletto, Massimo Molteni, Antonio M. Persico |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/2/164 |
Similar Items
-
Neurodevelopmental Disorders: The Journey, the Dreams and their Realization
by: Sheffali Gulati
Published: (2017-01-01) -
Genome-wide expression studies in Autism spectrum disorder, Rett syndrome, and Down syndrome
by: Carla Lintas, et al.
Published: (2012-01-01) -
Multifactorial Origin of Neurodevelopmental Disorders: Approaches to Understanding Complex Etiologies
by: Alessia De Felice, et al.
Published: (2015-03-01) -
Understanding the Link Between Allergy and Neurodevelopmental Disorders: A Current Review of Factors and Mechanisms
by: Regena Xin Yi Chua, et al.
Published: (2021-02-01) -
Postural Control in Childhood: Investigating the Neurodevelopmental Gradient Hypothesis
by: Leonardo Zoccante, et al.
Published: (2021-02-01)